Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Brotons

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Family Practice|October 26, 2005
Consequences of using different methods to assess cardiovascular risk in primary careMarco Fornasini, Carlos Brotons, Jaume Sellarès, et al.
Medicina Clinica|January 12, 2017
Erratum to "Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years"Carlos Brotons, Irene Moral, Diana Fernández, et al.
Medicina Clinica|November 1, 2011
[Inertia and treatment compliance in patients with type 2 diabetes in primary care]Flora López-Simarro, Carlos Brotons, Irene Moral, et al.
European Addiction Research|November 29, 2018
Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary CarePhilippe Castera, Edmund Stewart, Josef Großkopf, et al.
International Journal of Environmental Research and Public Health|November 11, 2022
Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-AnalysisCaterina Checa, Carlos Canelo-Aybar, Stefanie Suclupe, et al.
Medicina Clinica|August 31, 2016
[Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years]Carlos Brotons, Irene Moral, Diana Fernández, et al.
Revista Espanola De Cardiologia|October 18, 2002
[Methods of reporting research-results and their influence on decision-making by cardiologists prescribing drugs for primary and secondary prevention]Carlos Brotons, Irene Moral, Aida Ribera, et al.
European Heart Journal|April 25, 2018
Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?David de Gonzalo-Calvo, Angela Vea, Christian Bär, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 14, 2024
Validation of the IberScore model in a primary care populationCarlos Fernández-Labandera Ramos, Irene Moral, Carlos Brotons, et al.
Bone|October 2, 2012
Use of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean regionCarlen Reyes, Francesc Formiga, Marta Coderch, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Family Practice|October 26, 2005
Consequences of using different methods to assess cardiovascular risk in primary careMarco Fornasini, Carlos Brotons, Jaume Sellarès, et al.
Medicina Clinica|January 12, 2017
Erratum to "Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years"Carlos Brotons, Irene Moral, Diana Fernández, et al.
Medicina Clinica|November 1, 2011
[Inertia and treatment compliance in patients with type 2 diabetes in primary care]Flora López-Simarro, Carlos Brotons, Irene Moral, et al.
European Addiction Research|November 29, 2018
Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary CarePhilippe Castera, Edmund Stewart, Josef Großkopf, et al.
International Journal of Environmental Research and Public Health|November 11, 2022
Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-AnalysisCaterina Checa, Carlos Canelo-Aybar, Stefanie Suclupe, et al.
Medicina Clinica|August 31, 2016
[Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years]Carlos Brotons, Irene Moral, Diana Fernández, et al.
Revista Espanola De Cardiologia|October 18, 2002
[Methods of reporting research-results and their influence on decision-making by cardiologists prescribing drugs for primary and secondary prevention]Carlos Brotons, Irene Moral, Aida Ribera, et al.
European Heart Journal|April 25, 2018
Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?David de Gonzalo-Calvo, Angela Vea, Christian Bär, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 14, 2024
Validation of the IberScore model in a primary care populationCarlos Fernández-Labandera Ramos, Irene Moral, Carlos Brotons, et al.
Bone|October 2, 2012
Use of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean regionCarlen Reyes, Francesc Formiga, Marta Coderch, et al.
Pageof 17